← Back to ledger
Reshoring dealannouncedJuly 29, 2026

Octapharma clears final approvals for $1.5B first U.S. plant

OctapharmaSCRock Hill

Octapharma received final approvals for its first U.S. manufacturing and production campus in Rock Hill. The 50-acre project is expected to create more than 1,500 jobs and establish domestic production of plasma-derived critical-care therapies used in emergency preparedness.

#biopharma#critical-care#supply-chain#reshoring#south-carolina

Sources

  1. Octapharma USA press releaseoctapharmausa.com · 2026-07-29
  2. South Carolina Governor's Officegovernor.sc.gov · 2026-07-29

Related Reshoring deal milestones

Reshoring dealIn progressOct 05, 2026

CAMINUS and Amprius Sign U.S. Pouch-Cell Manufacturing Agreement

CAMINUS will manufacture Amprius-designed silicon-anode pouch cells at its Indianapolis facility under a contract announced October 5. Qualification builds are underway, and the companies plan to begin volume production in the first quarter of 2027 for aviation, defense, and uncrewed-system customers.

CAMINUSINIndianapolis